We found that the expression of the antiviral genes negatively correlated (except ADAM7, ADAM11, ADAM12, ADAM18, ADAM20, and ADAM29) with the HRCT score of the COVID-19 patients suggesting association of increased antiviral response with decreased disease severity (Figure 3D). This evidence concerns the gene ADAM29 and COVID-19.